Stocks
Black Diamond Therapeutics (BDTX) EBITDA US GAAP (year values) |
||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | |||
| EBITDA, bln rub | ? | -126.7 | -92.3 | -86.0 | -78.4 | 20.2 | -40.3 | |
| Changes by years, y/y, % | +90% | -27% | -7% | -9% | -126% | |||
Black Diamond Therapeutics. EBITDA US GAAP, bln rub
Black Diamond Therapeutics. EBITDA US GAAP, changes, %
Black Diamond Therapeutics. EBITDA US GAAP, sum by quarters, bln rub
Black Diamond Therapeutics (BDTX) EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EBITDA, bln rub | ? | 54.6 | -10.5 | -8.41 | -10.2 | -11.3 | -40.3 | |
| Changes by years, y/y, % | -371% | -52% | -53% | -44% | -121% | |||
| Changes by quarters, q/q, % | -400% | -119% | -20% | +21% | +10% | |||
